(Q81978749)

inferred from isomeric SMILES

stereoisomer of

(1R,2R,1'S,2'R)-(+/-)-atracurium

2 references

(1S,2R,1'S,2'R)-(+/-)-atracurium

inferred from InChI

2 references

(1R,2R,1'R,2'S)-(+/-)-atracurium

inferred from InChI

2 references

1 reference

chemical formula

C₅₃H₇₂N₂O₁₂²⁺

1 reference

inferred from SMILES

canonical SMILES

COc1ccc(CC2c3cc(OC)c(OC)cc3CC[N+]2(C)CCC(=O)OCCCCCOC(=O)CC[N+]2(C)CCc3cc(OC)c(OC)cc3C2Cc2ccc(OC)c(OC)c2)cc1OC

1 reference

inferred from isomeric SMILES

isomeric SMILES

C[N@@+]1(CCC2=CC(=C(C=C2[C@H]1CC3=CC(=C(C=C3)OC)OC)OC)OC)CCC(=O)OCCCCCOC(=O)CC[N@+]4(CCC5=CC(=C(C=C5[C@H]4CC6=CC(=C(C=C6)OC)OC)OC)OC)C

0 references

significant drug interaction

methylprednisolone

1 reference

A reference set of clinically relevant adverse drug-drug interactions

methylprednisolone

1 reference

A reference set of clinically relevant adverse drug-drug interactions

dexamethasone

1 reference

A reference set of clinically relevant adverse drug-drug interactions

dexamethasone

1 reference

A reference set of clinically relevant adverse drug-drug interactions

prednisolone

1 reference

A reference set of clinically relevant adverse drug-drug interactions

prednisolone

1 reference

A reference set of clinically relevant adverse drug-drug interactions

prednisone

1 reference

A reference set of clinically relevant adverse drug-drug interactions

prednisone

1 reference

A reference set of clinically relevant adverse drug-drug interactions

triamcinolone

1 reference

A reference set of clinically relevant adverse drug-drug interactions

triamcinolone

1 reference

A reference set of clinically relevant adverse drug-drug interactions

betamethasone

1 reference

A reference set of clinically relevant adverse drug-drug interactions

betamethasone

1 reference

A reference set of clinically relevant adverse drug-drug interactions

amikacin

1 reference

A reference set of clinically relevant adverse drug-drug interactions

amikacin

central respiratory depression

1 reference

A reference set of clinically relevant adverse drug-drug interactions

amikacin

paresis

1 reference

A reference set of clinically relevant adverse drug-drug interactions

streptomycin

1 reference

A reference set of clinically relevant adverse drug-drug interactions

streptomycin

central respiratory depression

1 reference

A reference set of clinically relevant adverse drug-drug interactions

streptomycin

paresis

1 reference

A reference set of clinically relevant adverse drug-drug interactions

tobramycin

1 reference

A reference set of clinically relevant adverse drug-drug interactions

tobramycin

central respiratory depression

1 reference

A reference set of clinically relevant adverse drug-drug interactions

tobramycin

paresis

1 reference

A reference set of clinically relevant adverse drug-drug interactions

different from

cisatracurium besylate

0 references

Identifiers

InChI

InChI=1S/C53H72N2O12/c1-54(22-18-38-32-48(62-7)50(64-9)34-40(38)42(54)28-36-14-16-44(58-3)46(30-36)60-5)24-20-52(56)66-26-12-11-13-27-67-53(57)21-25-55(2)23-19-39-33-49(63-8)51(65-10)35-41(39)43(55)29-37-15-17-45(59-4)47(31-37)61-6/h14-17,30-35,42-43H,11-13,18-29H2,1-10H3/q+2/t42-,43-,54-,55-/m1/s1

0 references

0 references

CAS Registry Number

96946-41-7

1 reference

https://commonchemistry.cas.org/detail?cas_rn=96946-41-7

10 April 2021

PubChem CID

62887

1 reference

ChEBI ID

140621

mapping relation type

exact match

2 references

ChEBI release 2021-03-01

International Chemical Identifier

InChI

InChI=1S/C53H72N2O12/c1-54(22-18-38-32-48(62-7)50(64-9)34-40(38)42(54)28-36-14-16-44(58-3)46(30-36)60-5)24-20-52(56)66-26-12-11-13-27-67-53(57)21-25-55(2)23-19-39-33-49(63-8)51(65-10)35-41(39)43(55)29-37-15-17-45(59-4)47(31-37)61-6/h14-17,30-35,42-43H,11-13,18-29H2,1-10H3/q+2/t42-,43-,54-,55-/m1/s1

1 reference

1 reference

DSSTOX compound identifier

0 references

0 references

1 reference

Human Metabolome Database ID

HMDB0240286

2 references

UNII

QX62KLI41N

1 reference

SKE79AOA7L

1 reference